{"name":"Tibotec BVBA","slug":"tibotec-bvba","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Telaprevir; Escitalopram","genericName":"Telaprevir; Escitalopram","slug":"telaprevir-escitalopram","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Telaprevir; Escitalopram","genericName":"Telaprevir; Escitalopram","slug":"telaprevir-escitalopram","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFB4dEFWNU5hUThxdGxialJuZVFFN3FJX2hhWlBvQlVqWkFIbnd4VjJlYXp4QU12SVBmdG5qd1Ezal9zR3VmdEg0V25FWU9sQzZZbWo3WjRsMnNVRHZpRTVPcEJaelI4ZFU2TlNIZTdYSTVVMDR1?oc=5","date":"2015-01-02","type":"trial","source":"Clinical Trials Arena","summary":"Incivek / Telaprevir – Treatment for Chronic Hepatitis C - Clinical Trials Arena","headline":"Incivek / Telaprevir – Treatment for Chronic Hepatitis C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPYXNMLWlTNDhEZzBlZ1FBcHZQX1VlQ2UtX29sU00wdXFMWHhicFRJUjFaZUw0YVNLU2JvUVZxSGpIREtYWmNPOFNHalZrbDFhOFlwbTVRc1liY2ZOTGJzcFVrNmxwQzRubF94Ul9SQ1FFRWpTamJZRmt6QUpQeTNKVA?oc=5","date":"2014-10-19","type":"trial","source":"Clinical Trials Arena","summary":"Harvoni (ledipasvir/sofosbuvir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection - Clinical Trials Arena","headline":"Harvoni (ledipasvir/sofosbuvir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}